A retrospective analysis of anti-osteoporosis medication trends among patients under 50 years old in nine major regions of China from 2016 to 2019.
The development of osteoporosis prescription in this study reflected the current situation of research in China. Meanwhile, in this study, we also investigated the epidemiology of osteoporosis in China in patients under 50 years of age, for whom the incidence of osteoporosis showed an increasing trend, which reminded us to accelerate the prevention of osteoporosis.
Authors
- Lian‐Di Kan (ORCID: https://orcid.org/0000-0001-5974-1290)
- Yan Hu (ORCID: https://orcid.org/0000-0002-9484-6546)
- Liucheng Li (ORCID: https://orcid.org/0000-0002-2511-0156)
- Zhenwei Yu (ORCID: https://orcid.org/0000-0002-3776-2290)
- Wang Chen (ORCID: https://orcid.org/0000-0003-0565-9157)
- Siqi Wang (ORCID: https://orcid.org/0000-0001-6136-2492)
- Liying Chen (ORCID: https://orcid.org/0000-0002-8895-3775)
- Bo Chen (ORCID: https://orcid.org/0000-0001-8356-0000)
- Yanting Sun (ORCID: https://orcid.org/0000-0003-1777-4697)
Institutions
- Sir Run Run Shaw Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.7717/peerj.19187
- Citations
- 1
- Primary Topic
- Bone Metabolism and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.81